Friday, Aug 12, 2022
×
Outlook.com
×

KEAM Result 2022 Expected To Be Released Today, Read Ahead To Know How To Check It

KEAM Result 2022 Expected To Be Released Today, Read Ahead To Know How To Check It

The Commissioner For Entrance Examinations, Government of Kerala is expected to release its KEAM Result 2022 on the official website on July 25th, 2022. The expected time associated with KEAM Result 2022 Date is 05:00 pm.

25 July 2022
Keep Faith On IT, Pharma, Banking Stocks: HDFC AMC’s Prashant Jain Advises Investors

Keep Faith On IT, Pharma, Banking Stocks: HDFC AMC’s Prashant Jain Advises Investors

Prashant Jain, the executive director and CIO of HDFC AMC shared his views on the ongoing stock market correction, the underlying opportunities, and how he...

15 June 2022

UP Investors Summit: PM Modi To Lay Foundation Stone Of Over 1,400 Projects

Prime Minister ​​​​​​​Narendra Modi will also be addressing a public function at Paraunkh village in Kanpur and visiting Pathri Mata Mandir with...

Zydus to supply product to US firm Sagent from Gujarat plant

Zydus to supply product to US firm Sagent from Gujarat plant

Zydus said it has received approval from the US Food and Drug Administration, which allows for a site transfer and manufacturing of the drug at Jarod.

13 April 2022

Lupin Launches Generic Contraceptive Drug In The US

The Mumbai-based drugmaker has launched the product in the US market under an exclusive license, marketing, and distribution agreement with Slayback Pharma LLC

Advertisement
07 April 2022
Lupin Acquires Portfolio Of Brands From Anglo-French Drugs & Industries

Lupin Acquires Portfolio Of Brands From Anglo-French Drugs & Industries

The acquisition will strengthen the company's India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements, and...


01 April 2022
Amfi lists out tier-one benchmarks for 67 types of MF schemes

Amfi lists out tier-one benchmarks for 67 types of MF schemes

Comes in wake of Sebi’s guidelines to bring in uniformity in benchmark of mutual fund schemes


21 March 2022
Alembic Pharma Gets USFDA Nod For Lacosamide Tablet

Alembic Pharma Gets USFDA Nod For Lacosamide Tablet

The approval by the USFDA is for the abbreviated new drug application (ANDA) for Lacosamide Tablets of strengths 50 mg, 100 mg, 150mg, and 200 mg.


21 March 2022
Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

The approval granted by the USFDA to the company's arm Glenmark Pharmaceuticals Inc, USA, is for Lacosamide tablets of strengths 50 mg, 100 mg, 150 mg, and 200...


14 March 2022
Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

Piramal Pharma said it is now strengthening the brand offering by introducing Tetmosol Dusting Powder and increasing its media investments subsequently.


Advertisement

27 February 2022
Suramin Reduces Drug Resistance In Mycobacteria, Says Study

Suramin Reduces Drug Resistance In Mycobacteria, Says Study

Strategies to tackle drug-resistant strains include identification of new antibiotics or targeting the bacterial mechanisms that reduce the rate of evolution...


22 January 2022
Covid-19: Indian-Origin Brothers In UK Offer Jabs With Kebabs Service

Covid-19: Indian-Origin Brothers In UK Offer Jabs With Kebabs Service

Covid-19: Rav and Raj Chopra, who own popular restaurant Punjabi Grill in Gravesend UK, set up the walk-in vaccine centre after their father became unwell with...


17 January 2022
Strides Pharma's Singapore arm gets USFDA nod for generic version of oseltamivir phosphate

Strides Pharma's Singapore arm gets USFDA nod for generic version of oseltamivir phosphate

Strides Pharma Science Ltd has received approval from the US health regulator for its generic version of oseltamivir phosphate for oral suspension, used for...


08 January 2022
USFDA Rejects Biocon, Viatris Application For Insulin Aspart

USFDA Rejects Biocon, Viatris Application For Insulin Aspart

Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for Insulin Aspart filed...


18 November 2021

"Pharmacy Of The World": India Delivers Over 65 Million Doses Of Covid Vaccines To 100 Countries This Year

"Our policy interventions are being made based on wide consultations with all stakeholders". Speaking at inaugurating the first global innovation summit of the...


03 September 2021
The Pharma IPO Boom Continues. Which Ones Will Stand Out?

The Pharma IPO Boom Continues. Which Ones Will Stand Out?

Despite the muted response to Vijaya Diagnostics IPO, the broader boom is likely to continue on the back of improved financials and the potential of the...


Advertisement
Advertisement
Advertisement
Advertisement
Advertisement